Log in automatically

Log in | New user?

Myriad Genetics

                   
timesonline.co.uk: This undated artist's depiction shows the aeroshell of NASA's Phoenix Mars Lander spacecraft as it enters the Martian atmosphere timesonline.co.uk

Medical research is ‘hindered by out-of-date laws’

System is inefficient and corrupt, say scientists Russell Jenkins and Mark Henderson Research into new medicines is being impaired by intellectual property laws that are no longer suited to modern science, two Nobel laureates...

analysis/comments

MYRIAD GENETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR...

yahoo.com     02-Jul-2008   8 related          

| Request a Trial to NEW EDGAR Online Pro Form 8-K for MYRIAD GENETICS INC Other Events, Financial Statements and Exhibits Item 8.01. Other Events On June 30, 2008, Myriad Genetics, Inc. (the Company) announced results of its...

analysis/comments

Flurizan failure does not end Alzheimer's hope

zdnet.com     01-Jul-2008   51 related          

Posted by Dana Blankenhorn @ 5:42 am in its late-stage trial does not end the debate we mentioned a few weeks ago concerning GSMs, amyloid plaques and Alzheimer’s Disease. (Picture from Myriad Genetics.) Myriad Genetics...

analysis/comments

BellwetherReport.com Analyst Report on MYGN, COST, SPWR and TROW

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. TORONTO--(Marketwire - July 1, 2008) - BellwetherReport.com is the leading online financial newsletter for investors seeking top...

analysis/comments

                   

Analyst Actions: Fortune Brands, Netflix, Myriad Genetics

Wachovia analyst Jonathan Feeney says, given Fortune Brands' new guidance, it looks like sales were slower than he thought, which was "clearly priced in." But he says he did not expect cost pressures from steel and particle...

analysis/comments

                   

Health Highlights: July 1, 2008 (HealthDay)

Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Experimental Alzheimer's Drug Ineffective The experimental Alzheimer's drug Flurizan produced disappointing results in a...

analysis/comments

Abbott, Boston Scientific Stents & Stuff (at CNBC)

yahoo.com     01-Jul-2008   1 related          

So, I can now safely say, with complete confidence, that Food and Drug Administration approval of the new Abbott drug-coated stent will not happen in the second quarter. Recently, at least a couple of analysts have been telling...

analysis/comments

Health Winners & Losers: Halozyme (at TheStreet.com)

yahoo.com     01-Jul-2008   12 related          

Health stocks traded Tuesday on a variety of business and regulatory news. The Nasdaq and Amex biotechnology indices hopped 1.7% and 1.4%, respectively. They outdid the Amex pharmaceutical index, which registered a 0.8% rise,...

analysis/comments

Genentech (DNA) NewsBite - DNA Rises as Competing Drug Fails

pharmiweb.co.uk     01-Jul-2008          

Posted on Monday, June 30, 2008 10:58 AM Genentech (DNA) opened at $73.53. So far today the stock has hit a low of $73.53 and a high of $74.81. DNA is now trading at $74.78, up 2.06 (2.83%). After hitting a one-year low of...

analysis/comments

Elan (ELN) NewsBite - Elan Rises on Competitors' Failed Drug Study

pharmiweb.co.uk     01-Jul-2008          

Posted on Monday, June 30, 2008 10:20 AM Elan Corp. (ELN) opened at 35.27. So far today, the stock has hit a low of 35.27 and a high of 35.85. ELN is now trading at 35.33, up 0.42 (1.19%). The stock hit its 52 week high of...

analysis/comments

1 2 3 4 5 next »

               

Send to a friend | Bookmark with | Subscribe to this